[Open clinical experience with uridine-diphosphoglucose in icterigenous liver diseases of acute and chronic course].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D002648:Child; D002908:Chronic Disease; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007565:Jaundice / Q000188:drug therapy* / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014539:Uridine Diphosphate Sugars / Q000008:administration & dosage / Q000627:therapeutic use*
D014539:Uridine Diphosphate Sugars; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin
Experiencia clinica abierta con uridin-difosfoglucosa en hepatopatías icterígenas de curso agudo y crónico.